EDGAR Filing Documents for 0001144204-05-003281

Form 8-K - Current report:

SEC Accession No. 0001144204-05-003281

Filing Date

2005-02-04

Accepted

2005-02-04 11:39:28

Documents

Period of Report

2004-07-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v012039_form8k.txt	8-K	8638
2		ex99_1.txt	EX-99.1	27949
3		ex99_2.txt	EX-99.2	26293
4		ex99_3.txt	EX-99.3	14801
5		ex99_4.txt	EX-99.4	6596
	Complete submission text file	0001144204-05-003281.txt		86531

Mailing Address 2408 TIMBERLOCH PLACE, SUITE B-7 THE WOODLANDS TX 77380

Business Address 2408 TIMBERLOCH PLACE, SUITE B-7 THE WOODLANDS TX 77380 (281)272-9331

PHARMAFRONTIERS CORP (Filer) CIK: 0001069308 (see all company filings)